New Developments in Immunotherapy for SCLC

By
Emily Salmini
-
0
111
Three emerging therapeutic options for small cell lung cancer include bispecific T cell engagers targeting delta-like ligand 3, chimeric antigen receptor T cells (CAR-T cells), and antibody–drug conjugates.
[Journal For Immunotherapy of Cancer]
Full Article